Financial toxicity’s new face: How Medicaid unwinding, insurance changes, and rising cost of living are reshaping cancer care
NCODA Oncology and Hematology Meeting Abstracts · 28.10.2026 · 2 (2)
DOI: 10.67209/varu7926 ↗Kurz gefasst
Fachartikel in der Zeitschrift NCODA Oncology and Hematology Meeting Abstracts, online erschienen am 28.10.2026. Verfasst von Caprina Tomlinson. Die Arbeit nennt 7 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Financial toxicity significantly limits equitable cancer care. Following the expiration of COVID-19 Public Health Emergency relief—including continuous Medicaid enrollment, enhanced Affordable Care Act (ACA) premium subsidies, and expanded nutrition assistance—oncology teams observed an operational shift. Financial toxicity transformed from localized, treatment-related costs to multidimensional socioeconomic and policy-driven macro barriers that heavily restrict care access.
Objectives
Describe how Medicaid unwinding, ACA affordability shifts, Supplemental Nutrition Assistance Program (SNAP) reductions, and inflation reshape financial toxicity. Discuss the collaborative workflow between oncology nurse navigators and financial/insurance teams to intercept care barriers. Identify clinical screening and targeted navigation workflows to maximize resource utilization and protect care equity. Significance: Financial distress among cancer patients increasingly stems from compounding systemic pressures rather than direct medical bills alone. Post-pandemic rollbacks of enhanced ACA premium tax credits led to a 13% decline in Marketplace enrollment (from 22.1 million in 2025 to 19.2 million in 2026), exposing patients to higher premiums, steeper deductibles, and complex insurance transitions. Combined with continuous Medicaid unwinding and food benefit reductions, persistent inflation causes documented care disruptions. Adaptability: To combat these obstacles, oncology programs must deploy a strict, bidirectional collaborative workflow. Oncology nurse navigators need to introduce new clinical touchpoints to systematically perform baseline financial toxicity screenings, immediately routing distressed patients to dedicated financial and insurance navigators. These specialized experts would then provide responsive benefits counseling, prior authorization management, and foundation assistance matching.
Conclusion
This integrated operational buffer would protect vulnerable patients from devastating insurance lapses and uncoordinated, policy-driven care disruptions. Currently, this workflow is not widely used across institutions. New approaches and creative solutions will have to be developed. Funding: Not applicable.
Zitieren
APA
Tomlinson, C. (2026). Financial toxicity’s new face: How Medicaid unwinding, insurance changes, and rising cost of living are reshaping cancer care. NCODA Oncology and Hematology Meeting Abstracts, 2(2). https://doi.org/10.67209/varu7926
Vancouver
Tomlinson C. Financial toxicity’s new face: How Medicaid unwinding, insurance changes, and rising cost of living are reshaping cancer care. NCODA Oncology and Hematology Meeting Abstracts. 2026;2(2). doi:10.67209/varu7926
BibTeX
@article{Tomlinson2026,
author = {Tomlinson, Caprina},
title = {Financial toxicity’s new face: How Medicaid unwinding, insurance changes, and rising cost of living are reshaping cancer care},
journal = {NCODA Oncology and Hematology Meeting Abstracts},
year = {2026},
volume = {2},
number = {2},
doi = {10.67209/varu7926}
}
EUVIMED